Septeka - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,128,528 | 939,540 | 1,143,648 | 1,193,800 | 1,507,245 | 1,613,949 | 1,850,105 | 2,251,163 |
| Profit before tax | 165,339 | 124,597 | 196,701 | 236,090 | 317,456 | 391,920 | 585,563 | 682,864 |
| Net profit | 138,338 | 104,740 | 166,212 | 199,446 | 269,855 | 331,777 | 496,669 | 572,967 |
| Equity | 444,092 | 548,833 | 715,045 | 914,491 | 1,066,345 | 1,398,122 | 1,331,114 | 1,709,080 |
| Liabilities | 164,657 | 432,375 | 287,676 | 155,522 | 184,103 | 219,831 | 325,497 | 180,614 |
| Non-current assets | 158,735 | 187,383 | 163,763 | 140,142 | 148,211 | 122,676 | 107,465 | 92,256 |
| Current assets | 447,818 | 792,151 | 837,687 | 928,872 | 1,098,857 | 1,492,463 | 1,546,682 | 1,797,239 |
| Total assets | 606,553 | 979,534 | 1,001,450 | 1,069,014 | 1,247,068 | 1,615,139 | 1,654,147 | 1,889,495 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 20,521 | 167,646 | 137,328 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -8.2% | -16.7% | +21.7% | +4.4% | +26.3% | +7.1% | +14.6% | +21.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 22.8% | 10.7% | 16.6% | 18.7% | 21.6% | 20.5% | 30.0% | 30.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 31.2% | 19.1% | 23.2% | 21.8% | 25.3% | 23.7% | 37.3% | 33.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 12.3% | 11.1% | 14.5% | 16.7% | 17.9% | 20.6% | 26.8% | 25.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 14.7% | 13.3% | 17.2% | 19.8% | 21.1% | 24.3% | 31.7% | 30.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.8 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 376,176 | 313,180 | 381,216 | 397,933 | 502,415 | 537,983 | 616,702 | 750,388 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Septeka - Social security debts
The company had no debts to Sodra
Septeka - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Septeka, UAB (code 301501622), is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €2.25M and net profit of €573.0K, resulting in a profit margin of 25.5%. The business has shown a consistent upward trend over the last three years: revenue rose from €1.61M in 2023 to €1.85M in 2024 and then to €2.25M in 2025, while net profit increased from €331.8K to €496.7K and then to €573.0K. At the end of 2025, total assets stood at €1.89M, with equity of €1.71M and liabilities of €180.6K. The balance sheet remained strongly equity-funded, with an equity ratio of 90.5% and a debt-to-equity ratio of 0.11. Asset turnover was 1.19x, ROE was 33.5%, and ROA was 30.3%. Revenue per employee reached €750.4K, and profit per employee was €191.0K, indicating high productivity.